Possible prognostic significance of P53 immunoreactive status of hepatic colorectal cancer metastases following surgical resection

European Journal of Cancer

Volumn 34, Issue 4, 1998, Pages 594-595

  Pocard, M ^a,b   Paradis, V ^a   Adam, R ^a   Reynes, M ^a   Bismuth, H ^a  

^a HÔPITAL PAUL BROUSSE   (France)

^b INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

COLORECTAL TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; LIVER TUMOR; METABOLISM; METASTASIS; PATHOLOGY;

COLORECTAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032011523     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)10024-7     Document Type: Article

References (5)

1. Hamelin R, Laurent-Puig P, Olschwang S, et al. Association of p53 mutations with short survival in colorectal cancer. Gastroenterology 1994, 106, 42-48.
2. Yamaguchi A, Nakagawara G, Kurosaka Y, Nischimura G, Yonemura Y, Miyazaki. p53 immunoreaction in endoscopic biopsy specimens of colorectal cancer, its prognostic significance. Er J Cancer 1993, 68, 399-402.
3. Zeng ZS, Sarkis AS, Zhang ZF, et al. p53 nuclear over-expression: an independent predictor of survival in lymph node positive colorectal cancer patients. J Clin Oncol 1994, 12, 2043-2050.
4. Hughes KS, Simon R, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery 1986, 100, 278-284.
5. Scheele J, Stangl R, Altendorf-Hofmann A, Gall FP. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 1991, 110, 13-29.